Stewart and Woodworth of Savills Studley represent EMD Serono Inc. in 202,000 s/f lease renewal

Rockland, MA According to Savills Studley, EMD Serono Inc. the U.S. operating entity of  Merck KGaA, has renewed its headquarters lease at One Technology Place for 202,000 s/f, becoming the second largest lease agreement in suburban Boston this year.

Mark Stewart and Steve Woodworth of Savills Studley’s Boston office represented EMD Serono in the leasing. Rich Beal of Perry Brokerage associates represented the owner, A.W. Perry, Inc.

“The South Shore has provided an effective headquarters location for EMD Serono for over two decades,” said Stewart. “The decision to renew the lease at One Technology Place in Rockland was a strategic and cost effective solution for the company.”

Savills Studley is one of the leading commercial real estate services firms specializing in tenant representation. Founded in 1954, the firm pioneered the conflict-free business model of representing only tenants in their commercial real estate transactions.

Today, supported by high quality market research and in-depth analysis, Savills Studley provides strategic real estate solutions to organizations across all industries. The firm’s comprehensive commercial real estate platform includes brokerage, project management, capital markets, consulting and corporate services. With 27 offices in the U.S. and a heritage of innovation, Savills Studley is well known for tenacious client advocacy and exceptional service.

The firm is part of London-headquartered Savills plc, the premier global real estate service provider with over 27,000 professionals and over 600 locations around the world. 

EMD Serono, the U.S. biopharmaceutical business of Merck KGaA, Darmstadt, Germany, is a leading U.S. biopharma company focused exclusively on specialty care. For more than 40 years, EMD Serono has integrated cutting-edge science, innovative products and devices, and industry-leading patient support and access programs. EMD Serono has deep expertise in neurology, fertility and endocrinology, as well as a robust pipeline of potential therapies in neurology, oncology, immunology and immuno-oncology. Today, EMD Serono has more than 1,100 employees around the country with commercial, clinical and research operations based in the company’s home state of Massachusetts.